BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2027.
World J Gastroenterol. Jan 7, 2027; 33(1): 122422
Published online Jan 7, 2027. doi: 10.3748/wjg.122422
Table 1 Baseline characteristics of patients with positive and negative pathologic upgrade, n (%)
Group
Positive (n = 148)
Negative (n = 224)
P value
General characteristicsAge (year)67.1 ± 9.366.9 ± 8.80.94
Sex (male/female)90/58118/1060.12
White light endoscopy characteristicsLesion size (cm)1.7 (0.8)1.1 (0.4)< 0.001
Location0.032
Antrum72 (49)143 (64)
Angularis31 (21)35 (16)
Gastric body38 (26)37 (17)
Cardia and others7 (4.7)9 (4.0)
Paris classification< 0.001
0-IIa41 (28)111 (50)
0-IIa + IIc23 (16)24 (11)
0-IIb37 (25)62 (28)
0-IIc41 (28)25 (11)
0-IIc + IIa6 (4.1)2 (0.9)
Background atrophy0.003
Mild12 (8.1)48 (21)
Moderate112 (76)148 (66)
Severe24 (16)28 (13)
Surface nodularity< 0.001
Present52 (35)19 (8.5)
Absent96 (65)205 (92)
Surface ulceration< 0.001
Present34 (23)11 (4.9)
Absent114 (77)213 (95)
Erythema< 0.001
Present96 (65)60 (27)
Absent52 (35)164 (73)
ME characteristicsMS pattern< 0.001
Irregular/absent130 (88)120 (54)
Regular18 (12)104 (46)
MV pattern< 0.001
Irregular/absent119 (80)87 (39)
Regular29 (20)137 (61)
Biopsy pathologyIntestinal metaplasia0.75
Present133 (90)199 (89)
Absent15 (10)25 (11)
Table 2 Subgroup analysis for predicting pathological upgrading
Stratification factors
Subgroups
Upgraded/non-upgraded (n)
AUC
DeepSeek-V3
Qwen3-235b
Lesion size (cm)< 119/940.790 (0.589-0.896)0.785 (0.617-0.889)
1-2103/1260.852 (0.793-0.892)0.837 (0.776-0.878)
≥ 226/40.594 (0.473-0.721)0.605 (0.305-0.765)
Postoperative pathologyHGIN105/2240.851 (0.795-0.886)0.846 (0.789-0.885)
EGC43/2240.924 (0.875-0.952)0.900 (0.849-0.934)


Write to the Help Desk